Darnytsia is a leading Ukrainian pharmaceutical company with over 90 years of history, specializing in the development, manufacturing, and distribution of a wide range of high-quality, affordable medicines. The company is a key player in Ukraine's healthcare system, adhering to European GMP (Good Manufacturing Practice) standards. Darnytsia focuses on producing generic drugs across various therapeutic areas, including cardiology, neurology, pain relief, and anti-infectives, contributing significantly to the nation's pharmaceutical independence and public health.
Serves as the central hub for administration, research and development, primary manufacturing operations, quality control, and strategic planning.
State-of-the-art manufacturing facilities compliant with international GMP standards, advanced R&D laboratories, and modern warehousing.
A professional environment focused on scientific innovation, quality assurance, continuous improvement, employee safety, and social responsibility. Emphasis on teamwork and adherence to high ethical standards.
The headquarters is the heart of Ukraine's largest domestic pharmaceutical producer, critical for national drug security, public health, and economic contribution to the pharmaceutical sector.
While primarily focused on the Ukrainian market, Darnytsia exports its pharmaceutical products to various countries, including those in the CIS region, the European Union, the Middle East, and Asia. Its global functions include export sales, international market regulatory compliance, and participation in global health initiatives and partnerships. This demonstrates an expanding international footprint.
13, Boryspilska Street
Kyiv
Kyiv City
Ukraine
Address: 13, Boryspilska Street, Kyiv, 02093, Ukraine (Primary Manufacturing and R&D site)
N/A - Primary operations are centralized. Distribution is managed nationally.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Darnytsia Pharmaceutical Company' leadership includes:
Darnytsia Pharmaceutical Company has been backed by several prominent investors over the years, including:
No major high-profile C-suite executive hires or departures have been widely publicized for Darnytsia in the last 12 months, suggesting stability in top leadership. Any changes are typically internal or not broadly announced.
Discover the tools Darnytsia Pharmaceutical Company uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Darnytsia likely uses standard corporate email formats. Common patterns include combining the first initial and last name, or first name and last name separated by a dot, followed by the company's domain.
[first_initial][last_name]@darnitsa.ua or [first_name].[last_name]@darnitsa.ua
Format
asmith@darnitsa.ua or anna.smith@darnitsa.ua
Example
80%
Success rate
Darnytsia Official Website / News Section • March 5, 2024
In February 2024, Darnytsia pharmaceutical company directed over UAH 11 million towards charitable initiatives. This aid included providing medicines to military personnel, medical institutions, and charitable foundations, supporting various humanitarian needs across Ukraine....more
European Pravda (citing Darnytsia) • February 12, 2024
The European Bank for Reconstruction and Development (EBRD) is providing a US$10 million loan to Darnytsia, Ukraine's largest pharmaceutical company. The funds are intended to support Darnytsia's working capital needs to ensure the continued supply of essential medicines....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Darnytsia Pharmaceutical Company, are just a search away.